Evidence map›Paper›PMID 36200046›Full record

ArticleFrontiers in cell and developmental biology2022

Expression of vimentin alters cell mechanics, cell-cell adhesion, and gene expression profiles suggesting the induction of a hybrid EMT in human mammary epithelial cells.

Suganya Sivagurunathan, Amir Vahabikashi, Haiqian Yang, Jun Zhang, Kelly Vazquez, Dhivyaa Rajasundaram, Yuliya Politanska, Hiam Abdala-Valencia, Jacob Notbohm, Ming Guo and 2 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in cell and developmental biology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
6.1field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 56 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Vimentin Intermediate Filaments: A Paradigm Shift From Static Structure to Dynamic Cytoplasmic Network.BioEssays : news and reviews in molecular, cellular and developmental biology · 2026
    Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Review
  17. Vimentin undergoes liquid-liquid phase separation to form droplets which wet and stabilize actin fibers.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 4 institutions in 1 country.

Suganya SivagurunathanDepartment of Cell and Developmental Biology, Feinberg School of Medicine, Northwestern University, Chicago, IL, United States.
Amir VahabikashiDepartment of Cell and Developmental Biology, Feinberg School of Medicine, Northwestern University, Chicago, IL, United States.
Haiqian YangDepartment of Mechanical Engineering , Massachusetts Institute of Technology , Cambridge , MA, United States.
Jun ZhangBiophysics Program, University of Wisconsin-Madison, Madison, WI, United States.
Kelly VazquezDepartment of Engineering Physics, University of Wisconsin-Madison, Madison, WI, United States.
Dhivyaa RajasundaramDepartment of Pediatrics, University of Pittsburgh School of Medicine, Pittsburgh, PA, United States.
Yuliya PolitanskaDepartment of Medicine, Feinberg School of Medicine, Northwestern University, Chicago, IL, United States.
Hiam Abdala-ValenciaDepartment of Medicine, Feinberg School of Medicine, Northwestern University, Chicago, IL, United States.
Jacob NotbohmBiophysics Program, University of Wisconsin-Madison, Madison, WI, United States.
Ming GuoDepartment of Mechanical Engineering , Massachusetts Institute of Technology , Cambridge , MA, United States.
Stephen A AdamDepartment of Cell and Developmental Biology, Feinberg School of Medicine, Northwestern University, Chicago, IL, United States.
Robert D GoldmanDepartment of Cell and Developmental Biology, Feinberg School of Medicine, Northwestern University, Chicago, IL, United States.
Northwestern University · USUniversity of Wisconsin–Madison · USMassachusetts Institute of Technology · USUniversity of Pittsburgh · US

Funding

Structural basis of the specific protein-protein interactions underlying IF assemP01GM096971 · NIGMS · NORTHWESTERN UNIVERSITY AT CHICAGO · PI GOLDMAN, ROBERT D · 2011 to 2021
$16.8M
Mechanobiology of Vimentin Intermediate Filaments in 3D Collective Cell MigrationR01GM140108 · NIGMS · MASSACHUSETTS INSTITUTE OF TECHNOLOGY · PI GUO, MING, WONG, IAN Y · 2021 to 2025
$2.3M
NIGMS NIH HHS P01 GM096971NIGMS NIH HHS R01 GM140108
6 · The paper itself

Abstract

Vimentin is a Type III intermediate filament (VIF) cytoskeletal protein that regulates the mechanical and migratory behavior of cells. Its expression is considered to be a marker for the epithelial to mesenchymal transition (EMT) that takes place in tumor metastasis. However, the molecular mechanisms regulated by the expression of vimentin in the EMT remain largely unexplored. We created MCF7 epithelial cell lines expressing vimentin from a cumate-inducible promoter to address this question. When vimentin expression was induced in these cells, extensive cytoplasmic VIF networks were assembled accompanied by changes in the organization of the endogenous keratin intermediate filament networks and disruption of desmosomes. Significant reductions in intercellular forces by the cells expressing VIFs were measured by quantitative monolayer traction force and stress microscopy. In contrast, laser trapping micro-rheology revealed that the cytoplasm of MCF7 cells expressing VIFs was stiffer than the uninduced cells. Vimentin expression activated transcription of genes involved in pathways responsible for cell migration and locomotion. Importantly, the EMT related transcription factor

Indexed as

cell-cell adhesiondesmoplakinhybrid/partial EMTintercellular forcesintracellular mechanicsTwist1vimentin

Identifiers

PMID36200046
PMCPMC9527304
OpenAlexW4296260932

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.